ID   WECA_ECOLI              Reviewed;         367 AA.
AC   P0AC78; P24235; P76751; Q2M892; Q9F8C8;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2005, sequence version 1.
DT   15-FEB-2017, entry version 103.
DE   RecName: Full=Undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase {ECO:0000255|HAMAP-Rule:MF_02030, ECO:0000305};
DE            EC=2.7.8.33 {ECO:0000255|HAMAP-Rule:MF_02030, ECO:0000269|PubMed:17237164, ECO:0000269|PubMed:9134438};
DE   AltName: Full=UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate transferase {ECO:0000255|HAMAP-Rule:MF_02030, ECO:0000303|PubMed:1730666};
DE   AltName: Full=Undecaprenyl-phosphate GlcNAc-1-phosphate transferase {ECO:0000255|HAMAP-Rule:MF_02030};
GN   Name=wecA {ECO:0000255|HAMAP-Rule:MF_02030,
GN   ECO:0000303|PubMed:10629198};
GN   Synonyms=rfe {ECO:0000303|PubMed:1722555};
GN   OrderedLocusNames=b3784, JW3758;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1722555; DOI=10.1111/j.1365-2958.1991.tb00809.x;
RA   Ohta M., Ina K., Kusuzaki K., Kido N., Arakawa Y., Kato N.;
RT   "Cloning and expression of the rfe-rff gene cluster of Escherichia
RT   coli.";
RL   Mol. Microbiol. 5:1853-1862(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION IN ECA BIOSYNTHESIS, AND
RP   PATHWAY.
RC   STRAIN=K12, and O8:K27;
RX   PubMed=1730666;
RA   Meier-Dieter U., Barr K., Starman R., Hatch L., Rick P.D.;
RT   "Nucleotide sequence of the Escherichia coli rfe gene involved in the
RT   synthesis of enterobacterial common antigen. Molecular cloning of the
RT   rfe-rff gene cluster.";
RL   J. Biol. Chem. 267:746-753(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12 / MB2884;
RX   PubMed=11024259; DOI=10.1111/j.1574-6968.2000.tb09335.x;
RA   Anderson M.S., Eveland S.S., Price N.P.J.;
RT   "Conserved cytoplasmic motifs that distinguish sub-groups of the
RT   polyprenol phosphate:N-acetylhexosamine-1-phosphate transferase
RT   family.";
RL   FEMS Microbiol. Lett. 191:169-175(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=1379743; DOI=10.1126/science.1379743;
RA   Daniels D.L., Plunkett G. III, Burland V.D., Blattner F.R.;
RT   "Analysis of the Escherichia coli genome: DNA sequence of the region
RT   from 84.5 to 86.5 minutes.";
RL   Science 257:771-778(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   SUBSTRATE SPECIFICITY.
RX   PubMed=9134438; DOI=10.1093/glycob/7.2.315;
RA   Rush J.S., Rick P.D., Waechter C.J.;
RT   "Polyisoprenyl phosphate specificity of UDP-GlcNAc:undecaprenyl
RT   phosphate N-acetylglucosaminyl 1-P transferase from E.coli.";
RL   Glycobiology 7:315-322(1997).
RN   [8]
RP   IDENTIFICATION OF START CODON.
RX   PubMed=10629198; DOI=10.1128/JB.182.2.498-503.2000;
RA   Amer A.O., Valvano M.A.;
RT   "The N-terminal region of the Escherichia coli WecA (Rfe) protein,
RT   containing three predicted transmembrane helices, is required for
RT   function but not for membrane insertion.";
RL   J. Bacteriol. 182:498-503(2000).
RN   [9]
RP   FUNCTION IN LPS O-ANTIGEN BIOSYNTHESIS, SUBCELLULAR LOCATION, PATHWAY,
RP   AND MUTAGENESIS OF ARG-265; HIS-279 AND 279-HIS--HIS-282.
RX   PubMed=11700352;
RA   Amer A.O., Valvano M.A.;
RT   "Conserved amino acid residues found in a predicted cytosolic domain
RT   of the lipopolysaccharide biosynthetic protein WecA are implicated in
RT   the recognition of UDP-N-acetylglucosamine.";
RL   Microbiology 147:3015-3025(2001).
RN   [10]
RP   MUTAGENESIS OF ASP-35; 90-ASP-ASP-91; ASP-94; ASP-156;
RP   156-ASP--ASP-159; ASP-159 AND ASP-276.
RX   PubMed=11832520;
RA   Amer A.O., Valvano M.A.;
RT   "Conserved aspartic acids are essential for the enzymic activity of
RT   the WecA protein initiating the biosynthesis of O-specific
RT   lipopolysaccharide and enterobacterial common antigen in Escherichia
RT   coli.";
RL   Microbiology 148:571-582(2002).
RN   [11]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND MUTAGENESIS OF ASP-90; ASP-91;
RP   ASP-156 AND ASP-159.
RX   PubMed=17237164; DOI=10.1128/JB.01905-06;
RA   Lehrer J., Vigeant K.A., Tatar L.D., Valvano M.A.;
RT   "Functional characterization and membrane topology of Escherichia coli
RT   WecA, a sugar-phosphate transferase initiating the biosynthesis of
RT   enterobacterial common antigen and O-antigen lipopolysaccharide.";
RL   J. Bacteriol. 189:2618-2628(2007).
CC   -!- FUNCTION: Catalyzes the transfer of the GlcNAc-1-phosphate moiety
CC       from UDP-GlcNAc onto the carrier lipid undecaprenyl phosphate
CC       (C55-P), yielding GlcNAc-pyrophosphoryl-undecaprenyl (GlcNAc-PP-
CC       C55). It is the first lipid-linked intermediate involved in
CC       enterobacterial common antigen (ECA) synthesis, and an acceptor
CC       for the addition of subsequent sugars to complete the biosynthesis
CC       of O-antigen lipopolysaccharide (LPS) in many E.coli O types. The
CC       apparent affinity of WecA for the polyisoprenyl phosphate
CC       substrates increases with the polyisoprenyl chain length. WecA is
CC       unable to utilize dolichyl phosphate (Dol-P).
CC       {ECO:0000269|PubMed:11700352, ECO:0000269|PubMed:17237164,
CC       ECO:0000269|PubMed:1730666, ECO:0000269|PubMed:9134438}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-glucosamine +
CC       ditrans,octacis-undecaprenyl phosphate = UMP + N-acetyl-alpha-D-
CC       glucosaminyl-diphospho-ditrans,octacis-undecaprenol.
CC       {ECO:0000255|HAMAP-Rule:MF_02030, ECO:0000269|PubMed:17237164,
CC       ECO:0000269|PubMed:9134438}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02030,
CC         ECO:0000269|PubMed:17237164};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02030,
CC         ECO:0000269|PubMed:17237164};
CC   -!- ENZYME REGULATION: Inhibited by tunicamycin.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.6 uM for UDP-GlcNAc {ECO:0000269|PubMed:9134438};
CC         KM=0.12 uM for UDP-GlcNAc (in the presence of Mg(2+))
CC         {ECO:0000269|PubMed:17237164};
CC         KM=0.19 uM for UDP-GlcNAc (in the presence of Mn(2+))
CC         {ECO:0000269|PubMed:17237164};
CC         KM=1.7 mM for Mg(2+) {ECO:0000269|PubMed:17237164};
CC         KM=0.3 mM for Mn(2+) {ECO:0000269|PubMed:17237164};
CC         Vmax=57 pmol/min/mg enzyme (in the presence of Mg(2+))
CC         {ECO:0000269|PubMed:17237164};
CC         Vmax=56 pmol/min/mg enzyme (in the presence of Mn(2+))
CC         {ECO:0000269|PubMed:17237164};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis. {ECO:0000255|HAMAP-Rule:MF_02030,
CC       ECO:0000269|PubMed:11700352}.
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; enterobacterial
CC       common antigen biosynthesis. {ECO:0000255|HAMAP-Rule:MF_02030,
CC       ECO:0000269|PubMed:1730666}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000255|HAMAP-
CC       Rule:MF_02030, ECO:0000269|PubMed:11700352,
CC       ECO:0000269|PubMed:15919996, ECO:0000269|PubMed:17237164}; Multi-
CC       pass membrane protein {ECO:0000255|HAMAP-Rule:MF_02030}.
CC       Note=Localizes to discrete regions in the plasma membrane.
CC       {ECO:0000269|PubMed:17237164}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 4 family. WecA
CC       subfamily. {ECO:0000255|HAMAP-Rule:MF_02030, ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA24526.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAB20842.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S75640; AAB20842.1; ALT_INIT; Genomic_DNA.
DR   EMBL; M76129; AAA24526.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF248031; AAG26342.1; -; Genomic_DNA.
DR   EMBL; M87049; AAA67584.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76789.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77514.1; -; Genomic_DNA.
DR   PIR; C65182; C65182.
DR   RefSeq; NP_418231.1; NC_000913.3.
DR   RefSeq; WP_001050960.1; NZ_LN832404.1.
DR   ProteinModelPortal; P0AC78; -.
DR   BioGrid; 4263322; 310.
DR   DIP; DIP-48083N; -.
DR   IntAct; P0AC78; 1.
DR   STRING; 511145.b3784; -.
DR   TCDB; 9.B.146.1.7; the putative undecaprenyl-phosphate n-acetylglucosaminyl transferase (murg) family.
DR   PaxDb; P0AC78; -.
DR   PRIDE; P0AC78; -.
DR   DNASU; 948789; -.
DR   EnsemblBacteria; AAC76789; AAC76789; b3784.
DR   EnsemblBacteria; BAE77514; BAE77514; BAE77514.
DR   GeneID; 948789; -.
DR   KEGG; ecj:JW3758; -.
DR   KEGG; eco:b3784; -.
DR   PATRIC; 32123061; VBIEscCol129921_3900.
DR   EchoBASE; EB0833; -.
DR   EcoGene; EG10840; wecA.
DR   eggNOG; ENOG4105ESV; Bacteria.
DR   eggNOG; COG0472; LUCA.
DR   HOGENOM; HOG000275125; -.
DR   InParanoid; P0AC78; -.
DR   KO; K02851; -.
DR   OMA; LPHNFQP; -.
DR   PhylomeDB; P0AC78; -.
DR   BioCyc; EcoCyc:GLCNACPTRANS-MONOMER; -.
DR   BioCyc; MetaCyc:GLCNACPTRANS-MONOMER; -.
DR   BRENDA; 2.7.8.33; 2026.
DR   UniPathway; UPA00281; -.
DR   UniPathway; UPA00566; -.
DR   PRO; PR:P0AC78; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0009276; C:Gram-negative-bacterium-type cell wall; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:EcoliWiki.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:EcoCyc.
DR   GO; GO:0005886; C:plasma membrane; IDA:EcoCyc.
DR   GO; GO:0008144; F:drug binding; IDA:EcoliWiki.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0008963; F:phospho-N-acetylmuramoyl-pentapeptide-transferase activity; IDA:EcoliWiki.
DR   GO; GO:0016780; F:phosphotransferase activity, for other substituted phosphate groups; IDA:UniProtKB.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; IEA:UniProtKB-KW.
DR   GO; GO:0036380; F:UDP-N-acetylglucosamine-undecaprenyl-phosphate N-acetylglucosaminephosphotransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044038; P:cell wall macromolecule biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0071555; P:cell wall organization; IDA:UniProtKB.
DR   GO; GO:0009246; P:enterobacterial common antigen biosynthetic process; IMP:EcoCyc.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IEA:UniProtKB-UniPathway.
DR   HAMAP; MF_02030; WecA_Gammaproteo; 1.
DR   InterPro; IPR012750; ECA_WecA-rel.
DR   InterPro; IPR000715; Glycosyl_transferase_4.
DR   PANTHER; PTHR22926; PTHR22926; 1.
DR   Pfam; PF00953; Glycos_transf_4; 1.
DR   TIGRFAMs; TIGR02380; ECA_wecA; 1.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Complete proteome;
KW   Glycosyltransferase; Lipopolysaccharide biosynthesis; Magnesium;
KW   Manganese; Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    367       Undecaprenyl-phosphate alpha-N-
FT                                acetylglucosaminyl 1-phosphate
FT                                transferase.
FT                                /FTId=PRO_0000108941.
FT   TOPO_DOM      1      2       Periplasmic. {ECO:0000305}.
FT   TRANSMEM      3     23       Helical. {ECO:0000255}.
FT   TOPO_DOM     24     45       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     46     66       Helical. {ECO:0000255}.
FT   TOPO_DOM     67     68       Periplasmic. {ECO:0000305}.
FT   TRANSMEM     69     89       Helical. {ECO:0000255}.
FT   TOPO_DOM     90    105       Cytoplasmic.
FT                                {ECO:0000269|PubMed:17237164}.
FT   TRANSMEM    106    126       Helical. {ECO:0000255}.
FT   TOPO_DOM    127    131       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    132    152       Helical. {ECO:0000255}.
FT   TOPO_DOM    153    157       Cytoplasmic.
FT                                {ECO:0000269|PubMed:17237164}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TOPO_DOM    179    186       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    187    207       Helical. {ECO:0000255}.
FT   TOPO_DOM    208    212       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    213    233       Helical. {ECO:0000255}.
FT   TOPO_DOM    234    241       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    242    262       Helical. {ECO:0000255}.
FT   TOPO_DOM    263    293       Cytoplasmic.
FT                                {ECO:0000269|PubMed:17237164}.
FT   TRANSMEM    294    314       Helical. {ECO:0000255}.
FT   TOPO_DOM    315    317       Periplasmic. {ECO:0000305}.
FT   TRANSMEM    318    338       Helical. {ECO:0000255}.
FT   TOPO_DOM    339    367       Cytoplasmic.
FT                                {ECO:0000269|PubMed:15919996,
FT                                ECO:0000269|PubMed:17237164}.
FT   SITE         90     90       Important in orienting the substrate.
FT                                {ECO:0000305|PubMed:11832520,
FT                                ECO:0000305|PubMed:17237164}.
FT   SITE         91     91       Important in orienting the substrate;
FT                                probably interacts with magnesium or
FT                                manganese. {ECO:0000305|PubMed:11832520,
FT                                ECO:0000305|PubMed:17237164}.
FT   SITE        156    156       Could be required for catalysis.
FT                                {ECO:0000305|PubMed:11832520,
FT                                ECO:0000305|PubMed:17237164}.
FT   SITE        159    159       Could be required for catalysis.
FT                                {ECO:0000305|PubMed:11832520,
FT                                ECO:0000305|PubMed:17237164}.
FT   MUTAGEN      35     35       D->G: Decrease in activity; both in vivo
FT                                and in vitro.
FT                                {ECO:0000269|PubMed:11832520}.
FT   MUTAGEN      90     91       DD->EE,GG: Loss of activity in vivo.
FT                                Decrease in activity in vitro. No change
FT                                in binding to tunicamycin.
FT                                {ECO:0000269|PubMed:11832520}.
FT   MUTAGEN      90     90       D->E,N: Reduces slightly the velocity and
FT                                shows a small increase of the affinity
FT                                for the transferase.
FT                                {ECO:0000269|PubMed:17237164}.
FT   MUTAGEN      91     91       D->N: Reduces slightly the velocity and
FT                                shows a small increase of the affinity
FT                                for the transferase.
FT                                {ECO:0000269|PubMed:17237164}.
FT   MUTAGEN      94     94       D->G: No loss in activity; both in vivo
FT                                and in vitro.
FT                                {ECO:0000269|PubMed:11832520}.
FT   MUTAGEN     156    156       D->E,N: Loss of activity.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     156    156       D->E: Loss of activity; both in vivo and
FT                                in vitro; when associated with E-159.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     156    156       D->G: Loss of activity; both in vivo and
FT                                in vitro. No binding to tunicamycin; when
FT                                associated with G-159.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     159    159       D->E,N: The activity is detectable but
FT                                drastically reduced.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     159    159       D->E: Loss of activity; both in vivo and
FT                                in vitro; when associated with E-156.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     159    159       D->G: Loss of activity; both in vivo and
FT                                in vitro. No binding to tunicamycin; when
FT                                associated with G-156.
FT                                {ECO:0000269|PubMed:11832520,
FT                                ECO:0000269|PubMed:17237164}.
FT   MUTAGEN     265    265       R->K: Decrease in activity. Reduces
FT                                binding to tunicamycin.
FT                                {ECO:0000269|PubMed:11700352}.
FT   MUTAGEN     276    276       D->G: No loss of activity; both in vivo
FT                                and in vitro.
FT                                {ECO:0000269|PubMed:11832520}.
FT   MUTAGEN     279    282       HIHH->GGGG: Loss of activity. No binding
FT                                to tunicamycin.
FT                                {ECO:0000269|PubMed:11700352}.
FT   MUTAGEN     279    279       H->S: Loss of activity. No binding to
FT                                tunicamycin.
FT                                {ECO:0000269|PubMed:11700352}.
FT   CONFLICT      8      8       T -> I (in Ref. 1; AAB20842).
FT                                {ECO:0000305}.
FT   CONFLICT     73     73       A -> V (in Ref. 1; AAB20842).
FT                                {ECO:0000305}.
FT   CONFLICT    116    116       K -> N (in Ref. 3; AAG26342).
FT                                {ECO:0000305}.
SQ   SEQUENCE   367 AA;  40957 MW;  6EB11CC80C6B9CC8 CRC64;
     MNLLTVSTDL ISIFLFTTLF LFFARKVAKK VGLVDKPNFR KRHQGLIPLV GGISVYAGIC
     FTFGIVDYYI PHASLYLACA GVLVFIGALD DRFDISVKIR ATIQAAVGIV MMVFGKLYLS
     SLGYIFGSWE MVLGPFGYFL TLFAVWAAIN AFNMVDGIDG LLGGLSCVSF AAIGMILWFD
     GQTSLAIWCF AMIAAILPYI MLNLGILGRR YKVFMGDAGS TLIGFTVIWI LLETTQGKTH
     PISPVTALWI IAIPLMDMVA IMYRRLRKGM SPFSPDRQHI HHLIMRAGFT SRQAFVLITL
     AAALLASIGV LAEYSHFVPE WVMLVLFLLA FFLYGYCIKR AWKVARFIKR VKRRLRRNRG
     GSPNLTK
//
